Search
 
News

Most common sources of low-value care: Laboratory testing and prescription drugs

In addition, low-value care is more prevalent in systems serving a higher proportion of non-white patients.

By Scott Wooldridge | October 11, 2021 at 09:28 AM
Even though health systems have strong incentives to provide efficient, high-value care, their makeup and bureaucracy might provide other incentives that result in low-value care.

A study in JAMA Internal Medicine provides new insights into low-value care—i.e., care that is provided and paid for but has little or questionable medical value. Low-value care has been identified as an area where U.S. health care costs could be reduced, if replaced by higher-value practices.

The study, by researchers at Harvard and Dartmouth, found that low-value care was found more often in U.S. health systems in the South and West, in systems that had relatively lower numbers of primary care providers, in systems without a major teaching hospital, and in systems that served a higher proportion of non-white patients.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

NOT FOR REPRINT

© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

 

Recommended Stories

New COVID variant is on the rise, has tripled in the past 2 weeks

New COVID variant is on the rise, has tripled in the past 2 weeks

Alan Goforth |

Although the pandemic is over, COVID-19 remains a persistent threat, as incidents of a highly mutated variant, BA.2.86, have tripled in the past 2 weeks but the CDC is confident the vaccines will be effective against the new strain.

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.